# OnCo record nct04266249 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04266249/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04266249", "NCT04266249" ;
  schema:name "CompassHER2-pCR"@en ;
  schema:alternateName "CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy"@en ;
  schema:description "CompassHER2-pCR tests whether people whose cancer clears with a shorter course of pre-surgery treatment can receive less chemotherapy afterward. Further treatment depends on what is found at surgery."@en ;
  schema:url <https://onco.cc/trials/nct04266249/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04266249>, <https://clinicaltrials.ucsf.edu/trial/NCT04266249> ;
  onco:status "active" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "2" ;
  schema:startDate "2020-03-13" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/pertuzumab/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/trastuzumab-emtansine/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .
